IRIS Accounts Production v24.2.0.383 12311210 director 1.12.22 30.11.23 30.11.23 false true false false false true false Ordinary A 0.01000 Ordinary B 0.01000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh123112102022-11-30123112102023-11-30123112102022-12-012023-11-30123112102021-11-30123112102021-12-012022-11-30123112102022-11-3012311210ns15:EnglandWales2022-12-012023-11-3012311210ns14:PoundSterling2022-12-012023-11-3012311210ns10:Director12022-12-012023-11-3012311210ns10:PrivateLimitedCompanyLtd2022-12-012023-11-3012311210ns10:SmallEntities2022-12-012023-11-3012311210ns10:AuditExempt-NoAccountantsReport2022-12-012023-11-3012311210ns10:SmallCompaniesRegimeForDirectorsReport2022-12-012023-11-3012311210ns10:SmallCompaniesRegimeForAccounts2022-12-012023-11-3012311210ns10:FullAccounts2022-12-012023-11-301231121012022-12-012023-11-3012311210ns10:OrdinaryShareClass12022-12-012023-11-3012311210ns10:OrdinaryShareClass22022-12-012023-11-3012311210ns10:RegisteredOffice2022-12-012023-11-3012311210ns5:CurrentFinancialInstruments2023-11-3012311210ns5:CurrentFinancialInstruments2022-11-3012311210ns5:ShareCapital2023-11-3012311210ns5:ShareCapital2022-11-3012311210ns5:RetainedEarningsAccumulatedLosses2023-11-3012311210ns5:RetainedEarningsAccumulatedLosses2022-11-3012311210ns5:NetGoodwill2022-12-012023-11-3012311210ns5:IntangibleAssetsOtherThanGoodwill2022-12-012023-11-3012311210ns5:PlantMachinery2022-12-012023-11-3012311210ns5:ComputerEquipment2022-12-012023-11-3012311210ns5:NetGoodwill2022-11-3012311210ns5:NetGoodwill2023-11-3012311210ns5:NetGoodwill2022-11-3012311210ns5:PlantMachinery2022-11-3012311210ns5:ComputerEquipment2022-11-3012311210ns5:PlantMachinery2023-11-3012311210ns5:ComputerEquipment2023-11-3012311210ns5:PlantMachinery2022-11-3012311210ns5:ComputerEquipment2022-11-3012311210ns5:AdditionsToInvestments2023-11-3012311210ns5:RevaluationsIncreaseDecreaseInInvestments2023-11-3012311210ns5:CostValuation2023-11-3012311210ns5:WithinOneYearns5:CurrentFinancialInstruments2023-11-3012311210ns5:WithinOneYearns5:CurrentFinancialInstruments2022-11-3012311210ns10:OrdinaryShareClass12023-11-3012311210ns10:OrdinaryShareClass22023-11-3012311210ns5:RetainedEarningsAccumulatedLosses2022-11-3012311210ns5:RetainedEarningsAccumulatedLosses2022-12-012023-11-30123112101ns10:Director12022-11-30123112101ns10:Director12021-11-30123112101ns10:Director12022-12-012023-11-30123112101ns10:Director12021-12-012022-11-30123112101ns10:Director12023-11-30123112101ns10:Director12022-11-30
REGISTERED NUMBER: 12311210 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 November 2023

for

South Coast Vascular Limited

South Coast Vascular Limited (Registered number: 12311210)






Contents of the Financial Statements
for the Year Ended 30 November 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


South Coast Vascular Limited

Company Information
for the Year Ended 30 November 2023







DIRECTOR: Mr L D Wijesinghe





REGISTERED OFFICE: Solent House
107a Alma Road
Southampton
SO14 6UY





REGISTERED NUMBER: 12311210 (England and Wales)





ACCOUNTANTS: Thomas Croft Limited
Accountants And Taxation Consultants
Solent House
107a Alma Road
Portswood
Southampton
Hampshire
SO14 6UY

South Coast Vascular Limited (Registered number: 12311210)

Balance Sheet
30 November 2023

30.11.23 30.11.22
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 10,000 20,000
Tangible assets 5 2,440 105
Investments 6 89,151 -
101,591 20,105

CURRENT ASSETS
Debtors 7 16,276 7,229
Cash at bank 75,472 199,268
91,748 206,497
CREDITORS
Amounts falling due within one year 8 16,051 81,236
NET CURRENT ASSETS 75,697 125,261
TOTAL ASSETS LESS CURRENT
LIABILITIES

177,288

145,366

CAPITAL AND RESERVES
Called up share capital 9 1 1
Retained earnings 10 177,287 145,365
SHAREHOLDERS' FUNDS 177,288 145,366

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

South Coast Vascular Limited (Registered number: 12311210)

Balance Sheet - continued
30 November 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 25 August 2024 and were signed by:





Mr L D Wijesinghe - Director


South Coast Vascular Limited (Registered number: 12311210)

Notes to the Financial Statements
for the Year Ended 30 November 2023

1. STATUTORY INFORMATION

South Coast Vascular Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2019, is being amortised evenly over its estimated useful life of five years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

South Coast Vascular Limited (Registered number: 12311210)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2023

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 December 2022
and 30 November 2023 50,000
AMORTISATION
At 1 December 2022 30,000
Amortisation for year 10,000
At 30 November 2023 40,000
NET BOOK VALUE
At 30 November 2023 10,000
At 30 November 2022 20,000

5. TANGIBLE FIXED ASSETS
Plant and Computer
machinery equipment Totals
£    £    £   
COST
At 1 December 2022 110 - 110
Additions - 2,361 2,361
At 30 November 2023 110 2,361 2,471
DEPRECIATION
At 1 December 2022 5 - 5
Charge for year 26 - 26
At 30 November 2023 31 - 31
NET BOOK VALUE
At 30 November 2023 79 2,361 2,440
At 30 November 2022 105 - 105

South Coast Vascular Limited (Registered number: 12311210)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2023

6. FIXED ASSET INVESTMENTS
Other
investments
£   
COST OR VALUATION
Additions 90,878
Revaluations (1,727 )
At 30 November 2023 89,151
NET BOOK VALUE
At 30 November 2023 89,151

Cost or valuation at 30 November 2023 is represented by:

Other
investments
£   
Valuation in 2023 89,151

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.23 30.11.22
£    £   
Trade debtors 9,551 -
Prepayments 6,725 7,229
16,276 7,229

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.23 30.11.22
£    £   
Corporation tax 10,237 18,919
Other creditors 1,000 235
Directors' current accounts 3,553 60,894
Accrued expenses 1,261 1,188
16,051 81,236

South Coast Vascular Limited (Registered number: 12311210)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2023

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.11.23 30.11.22
value: £    £   
60 Ordinary A £0.01 1 1
40 Ordinary B £0.01 - -
1 1

10. RESERVES
Retained
earnings
£   

At 1 December 2022 145,365
Profit for the year 33,922
Dividends (2,000 )
At 30 November 2023 177,287

11. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30 November 2023 and 30 November 2022:

30.11.23 30.11.22
£    £   
Mr L D Wijesinghe
Balance outstanding at start of year (60,894 ) (59,557 )
Amounts advanced 59,557 65
Amounts repaid (2,215 ) (1,402 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (3,552 ) (60,894 )